InsidersTradesSigma
Follow the PolyPeptide Group AG stock price and the full directors' dealings record of the company, a listed equity based in Switzerland. Shares trade on the CH market, under the supervision of SIX SER. Operating in the Health Care sector, PolyPeptide Group AG has published 10 insider filings. Market capitalisation: €1.5bn. The latest transaction was reported on 9 April 2025 (Purchase). Every trade is accessible without an account.
10
Insider Decl.
n/a
Thresholds
€4m
10 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate PolyPeptide Group AG Buy (bullish), based on 6 analysts. Average price target: CHF 38.81.
28Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,688 of 29,064 companies
19.9
score / 100
Value20
Quality20
FCF yld-2.2%
Earn yld-1.5%
EV/EBITDA55.8x
ROE-6.1%
Gross mgn17%
Net mgn-5.4%
Debt/EBITDA4.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 April 2025
Declarations10 total
1 shares@ CHF 75,000.0017.9% of flowISIN CH1110760852SIX:T1P49000D5
1 shares@ CHF 72,000.0017.2% of flowISIN CH1110760852SIX:T1P49000C7
1 shares@ CHF 50,000.0011.9% of flowISIN CH1110760852SIX:T1P49000B9
1 shares@ CHF 35,000.008.0% of flowISIN CH1110760852SIX:T1O4B00058
1 shares@ CHF 72,000.0016.5% of flowISIN CH1110760852SIX:T1O4B00033
1 shares@ CHF 75,000.0017.2% of flowISIN CH1110760852SIX:T1O4B00066
1 shares@ CHF 50,000.0011.4% of flowISIN CH1110760852SIX:T1O4B00041
●
Anonymous (Executive member of the board of directors / member of senior management)
2,500 shares@ CHF 20.500.0062% mcap1.5% of flowISIN CH1110760852SIX:T1NBA00094
159,959 shares@ CHF 17.98180.35% mcap87.2% of flowISIN CH1110760852SIX:T1NAB00037
●
Anonymous (Executive member of the board of directors / member of senior management)
22,041 shares@ CHF 16.84150.045% mcap11.2% of flowISIN CH1110760852SIX:T1NAA00062
10 of 10 declarations
关于 PolyPeptide Group AG
PolyPeptide Group AG 是一家专注于为制药和生物制药领域开发和制造多肽的公司。它在瑞士证券交易所 (XSWX) 上市。